May 18, 2021 / 03:00PM GMT
Lisa Hortense Maria De Neve - Morgan Stanley, Research Division - Equity Analyst
Welcome to the Amyris fireside chat. I have John Melo, Chief Executive Officer of Amyris, here with me. I will now pass on the word to him and after that we can jump into the Q&A. John, the floor is yours.
John G. Melo - Amyris, Inc. - President, CEO & Director
Great, Lisa, first of all, thank you for having us on. It's great to be with everyone. I thought I might share a little bit about Amyris and what we do before getting into the Q&A. At Amyris, we're the world's leading synthetic biology platform. We focus on that platform being applied through, really, a series of different end markets. And the way to think about it is, we're very focused in beauty in a direct-to-consumer business that has one of the leading brand portfolios in the world, which we can describe.
And then secondly, we're able to provide ingredients to some of the world's leading companies, really to help supply the growing demand, the growing consumer shift, to sustainable, clean ingredients
Amyris Inc at Morgan Stanley Global Ingredients Conference (Virtual) Transcript
May 18, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers